1. Home
  2. HTCR vs CTSO Comparison

HTCR vs CTSO Comparison

Compare HTCR & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTCR
  • CTSO
  • Stock Information
  • Founded
  • HTCR 2009
  • CTSO 1997
  • Country
  • HTCR Japan
  • CTSO United States
  • Employees
  • HTCR N/A
  • CTSO N/A
  • Industry
  • HTCR EDP Services
  • CTSO Medical/Dental Instruments
  • Sector
  • HTCR Technology
  • CTSO Health Care
  • Exchange
  • HTCR Nasdaq
  • CTSO Nasdaq
  • Market Cap
  • HTCR 13.6M
  • CTSO 68.2M
  • IPO Year
  • HTCR 2022
  • CTSO N/A
  • Fundamental
  • Price
  • HTCR $0.60
  • CTSO $0.87
  • Analyst Decision
  • HTCR
  • CTSO Strong Buy
  • Analyst Count
  • HTCR 0
  • CTSO 3
  • Target Price
  • HTCR N/A
  • CTSO $4.67
  • AVG Volume (30 Days)
  • HTCR 45.3K
  • CTSO 138.7K
  • Earning Date
  • HTCR 05-20-2025
  • CTSO 05-14-2025
  • Dividend Yield
  • HTCR 3.51%
  • CTSO N/A
  • EPS Growth
  • HTCR N/A
  • CTSO N/A
  • EPS
  • HTCR N/A
  • CTSO N/A
  • Revenue
  • HTCR $30,407,229.00
  • CTSO $35,594,520.00
  • Revenue This Year
  • HTCR N/A
  • CTSO $18.72
  • Revenue Next Year
  • HTCR N/A
  • CTSO $19.75
  • P/E Ratio
  • HTCR N/A
  • CTSO N/A
  • Revenue Growth
  • HTCR 39.19
  • CTSO 14.51
  • 52 Week Low
  • HTCR $0.52
  • CTSO $0.70
  • 52 Week High
  • HTCR $3.38
  • CTSO $1.61
  • Technical
  • Relative Strength Index (RSI)
  • HTCR 42.11
  • CTSO 33.89
  • Support Level
  • HTCR $0.53
  • CTSO $0.87
  • Resistance Level
  • HTCR $0.61
  • CTSO $1.16
  • Average True Range (ATR)
  • HTCR 0.05
  • CTSO 0.07
  • MACD
  • HTCR 0.02
  • CTSO -0.02
  • Stochastic Oscillator
  • HTCR 59.69
  • CTSO 0.00

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: